GLOBAL HEALTH VENTURES, INC
CURRENT PRICE – .0612
The Stock Wizards previous featured profile 3D Icon Corporation (TDCP.OB) continues to run closing at .0755 today, up over 57% from our initial alert last week.
Our newest featured profile is Global Health Ventures, Inc (GHLV.OB), a specialty pharmaceutical company with expertise in drug delivery and formulation. The Company has a proprietary platform technology for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with minimal drug breakdown in the liver or gastrointestinal system, a process that can greatly reduce side effects associated with the drugs.
GHLV’s lead therapeutic product is a male sexual enhancement drug that is delivered via sublingual route and is called X-Excite. In experimental studies, X-Excite has been shown to reach the blood stream rapidly, producing maximal effect and having less of the unwanted side effects associated with oral delivery route. X-Excite is presently in clinical development in Europe. The Company’s second drug “Relax-B” is also under development in Canada for anxiety. And, the third drug will be an anti-migraine drug.
GHLV plans to use the same technology to deliver a vast number of other FDA approved and non-approved drugs that require faster delivery, or reduced hepatic and gastrointestinal side effects. These include stress, sleeping disorders, pain killers, anti-allergy medications, heart and lung medication, migraine and addiction replacement therapies.
GHLV made our most recent weekly top 10 list when the stock was trading at just .0489 cents. The Stock Wizards is particularly impressed with this Company’s lead product, X-Excite, a male sexual enhancement drug. X-Excite is a sublingual formulation of sildenafil citrate. According to the Company’s website, Sildenafil citrate is used to make one of Pfizer Incorporated’s largest sellers Viagra®.
It is scientifically known that sublingual delivery is the fastest way to get a drug into the blood and bypass the liver as first passage to the body. Many of the side effects of drugs are due to their liver metabolism and use of liver as first passage to the body. Global Health’s sublingual delivery, which delivers the drug directly to the blood, should have fewer side effects, in theory then similar erectile dysfunction drug on the market known as Viagra®.
GHLV is coming out of a 2 month base which gives traders something to work with. GHLV is currently trading above the 100-day moving average (.0431) which is critical support. GHLV made a nice move the last two trading sessions to close at .0612 and appears to be trending higher on nice volume.
TheStockWizards.net is not a registered investment advisers or broker/dealer. TheStockWizards.net makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. TheStockWizards.net is compliant with The Can Spam Act of 2003.
Forward-Looking Statement: This advertisiment profile includes “forward-looking statements” within the meaning of the federal securities laws, commonly identified by such terms as “believes,” “looking ahead,” “anticipates,” “estimates” and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s projections and expectations are disclosed in the Company’s filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TheStockWizards.net strongly urges you to conduct a complete due diligence of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TheStockWizards.net does not offer such advice or analysis, and TheStockWizards.net urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
PLEASE NOTE: TheStockWizards.net has not been compensated for the above profile. However, if or when compensated, any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. When compensated by a third party, please be fully aware that the third party may have shares and may liquidate it, which may negatively affect the market. When TheStockWizards.net receives free trading shares as compensation for a profiled company, TheStockWizards.net may sell part or all of any such shares during the period in which TheStockWizards.net is performing such services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. In addition, there may be members on this board that receive compensation for particular stock awareness without telling members, so please always use your own buy and sell signals based on your own decisions. Any recent increase in volume or increase in stock price may be due to The StockWizards.com representatives buying. The Stock Wizards intend to sell shares received as compensation for providing Company Background Information, sending opt-in emails, posting charts, videos, site moderation, consulting etc. We do not give price targets in any of our written or recorded material. TheStockWizards.net will not advise as to when we decide to sell and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. Please do your own research and make your own investment decisions. Always remember that TheStockWizards.net is not an analyst and we do not employ or contract any analysts. In preparing profile publication, TheStockWizards.net have relied upon information supplied by its customers and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in these websites. Rather, investors should use the information contained in these websites as a starting point for doing additional independent research on the featured companies. Investing in securities such as the ones mentioned on our website, in email, or consulted for are for high-risk tolerant individuals only and not the general public.
Many of the companies communicated in our emails or website are developmental stage companies with little or no operating or trading history. The information contained in our alerts should be viewed as commercial advertisement and is not intended to be investment opinion. The report is not provided to any particular individual with a view toward their investment circumstances. The information contained in our alerts is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge to individuals who wish to receive them. Our advertisements and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiles based solely on information contained in our report. Individuals should assume that all information contained in the alerts about profiled companies is not trust worthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some of all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Release of Liability: Through use of this website viewing or using you agree to hold TheStockWizards.net, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources, which we believe to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TheStockWizards.net affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. TheStockWizards.net encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TheStockWizards.net makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. In preparing this publication, TheStockWizards.net has relied upon information supplied by its customers, and press releases, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies.